IDXX
IDEXX Laboratories Inc
513.40$
-1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.6% | +2.9% | +1.8% | -1.9% | -1.7% | -2.4% | +3.6% | +1.7% | -1.1% | +1.0% | +1.7% | |
| – | +8.0% | +0.4% | +1.8% | -6.2% | -2.4% | -5.9% | +3.4% | +3.3% | -4.7% | +8.5% | +3.8% | |
| – | +36.9% | -12.4% | +1.0% | -23.1% | -6.6% | -43.1% | +0.4% | +26.5% | -13.5% | +11.4% | -1.8% | |
| – | +36.9% | -12.4% | +1.0% | -23.1% | -6.6% | -43.1% | +0.4% | +26.5% | -13.5% | +11.4% | -1.8% | |
| – | +1.5% | +9.2% | +5.2% | -3.5% | -19.3% | +27.6% | +9.8% | +7.8% | -3.0% | +0.6% | +6.4% | |
| – | -3.5% | +2.7% | -2.7% | +2.6% | -2.0% | +3.7% | -0.9% | -0.3% | -3.5% | +1.2% | +2.4% | |
| – | +1.2% | +11.7% | -0.2% | +1.0% | -1.7% | +0.6% | +1.7% | -0.2% | +0.1% | -0.5% | -0.3% | |
| – | -3.0% | +36.5% | -3.9% | -3.5% | +4.5% | -3.8% | -3.4% | +10.7% | -4.3% | -4.6% | -6.3% | |
| – | -0.8% | +0.5% | +2.8% | -5.6% | -2.0% | +4.0% | +6.0% | -2.5% | -4.4% | +4.8% | +0.0% | |
| – | -1.9% | +0.6% | +16.7% | -9.6% | +5.8% | +6.4% | +7.7% | +2.3% | -8.2% | +13.1% | -0.9% | |
| – | -17.9% | -0.1% | +27.8% | -15.9% | -54.7% | +205.5% | +32.6% | -7.1% | -20.8% | +41.4% | -1.6% | |
| – | -1.7% | +6.2% | +0.0% | -5.8% | +3.3% | +5.2% | -2.9% | +4.9% | -9.7% | +17.7% | -0.7% | |
| – | +0.7% | -0.3% | -15.5% | +0.0% | -14.3% | +0.0% | +0.0% | -16.7% | +0.0% | -20.0% | +0.0% | |
| – | +14.4% | +5.7% | +0.7% | +2.4% | -1.4% | -9.2% | +0.7% | +7.0% | +2.8% | -3.1% | +3.6% | |
| – | +4.6% | +5.3% | +4.3% | +4.8% | +4.2% | +4.6% | +5.3% | +4.7% | +4.0% | +4.4% | +5.1% | |
| – | -0.1% | +0.0% | -0.7% | -0.4% | +0.0% | -1.4% | -1.1% | -0.4% | +0.0% | +0.0% | +0.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.